合計 50 件の最近のインサイダー取引記録が記録されています Keros Therapeutics, Inc. (KROS), 内訳は 23 件の買い および 16 件の売り. インサイダー買い総額は $17.44M インサイダー売り総額は $23.86M.
最近活動のある主要インサイダーには Seehra Jasbir, Bienaime Jean Jacques, Newton Charles W.. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — KROS
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2026-04-02 |
Seehra Jasbir |
Chief Executive Officer |
オプション行使（売却） |
55,000 |
$0.30 |
$16.5K |
197,444 |
| 2026-03-09 |
Bienaime Jean Jacques |
Director |
情報に基づく買い |
2,000 |
$11.21 |
$22.42K |
7,450 |
| 2026-03-09 |
Newton Charles W. |
Officer |
不明 |
- |
- |
- |
- |
| 2026-03-09 |
Newton Charles W. |
Director |
RSU 付与（制限付株式） |
13,215 |
- |
- |
13,215 |
| 2026-02-24 |
Regnante Keith |
Chief Financial Officer |
RSU 付与（制限付株式） |
60,000 |
$15.52 |
$931.2K |
60,000 |
| 2026-02-24 |
Seehra Jasbir |
Chief Executive Officer |
RSU 付与（制限付株式） |
100,000 |
$15.52 |
$1.55M |
100,000 |
| 2026-02-24 |
Cho Esther |
Chief Legal Officer |
RSU 付与（制限付株式） |
80,000 |
$15.52 |
$1.24M |
80,000 |
| 2026-02-19 |
Seehra Jasbir |
Chief Executive Officer |
情報に基づく売り |
7,015 |
$16.17 |
$113.43K |
385,708 |
| 2026-02-18 |
Regnante Keith |
Chief Financial Officer |
情報に基づく売り |
4,739 |
$16.35 |
$77.48K |
39,261 |
| 2026-02-18 |
Lerner Lorena Raquel |
Chief Science Officer |
情報に基づく売り |
3,873 |
$16.35 |
$63.32K |
31,127 |
| 2026-02-18 |
Cho Esther |
SVP, General Counsel |
情報に基づく売り |
4,745 |
$16.35 |
$77.58K |
39,755 |
| 2026-01-07 |
Seehra Jasbir |
Chief Executive Officer |
RSU 付与（制限付株式） |
62,500 |
$63.61 |
$3.98M |
62,500 |
| 2025-11-21 |
Orbimed Advisors Llc |
Director |
株式返還 |
74,465 |
$17.75 |
$1.32M |
45,057 |
| 2025-11-21 |
Gordon Carl L |
Director |
株式返還 |
74,465 |
$17.75 |
$1.32M |
45,057 |
| 2025-11-21 |
Knowles Julius |
Director |
株式返還 |
130,494 |
$17.75 |
$2.32M |
102,233 |
| 2025-10-15 |
Adar1 Capital Management, Llc |
10 Percent Owner |
情報に基づく売り |
743,358 |
$17.75 |
$13.19M |
- |
| 2025-10-15 |
Pontifax Management 4 G.p. (2015) Ltd. |
10 Percent Owner |
情報に基づく売り |
155,262 |
$17.75 |
$2.76M |
- |
| 2025-09-03 |
Seehra Jasbir |
Chief Executive Officer |
RSU 付与（制限付株式） |
90,500 |
- |
- |
392,723 |
| 2025-08-06 |
Lerner Lorena Raquel |
Chief Science Officer |
不明 |
10,879 |
$43.99 |
$478.57K |
- |
| 2025-08-06 |
Cho Esther |
SVP, General Counsel |
不明 |
50,000 |
$54.38 |
$2.72M |
- |
| 2025-06-20 |
Adar1 Capital Management, Llc |
10 Percent Owner |
オプション行使（ITM） |
1 |
$60.00 |
$60.00 |
- |
| 2025-06-04 |
Bienaime Jean Jacques |
Director |
RSU 付与（制限付株式） |
5,250 |
- |
- |
5,450 |
| 2025-06-04 |
Gray Mary Ann |
Director |
RSU 付与（制限付株式） |
5,250 |
- |
- |
5,250 |
| 2025-06-04 |
Gordon Carl L |
Director |
RSU 付与（制限付株式） |
5,250 |
- |
- |
5,250 |
| 2025-06-04 |
Kariv Tomer |
10 Percent Owner |
RSU 付与（制限付株式） |
5,250 |
- |
- |
5,250 |
| 2025-06-04 |
Nussbaum Ran |
10 Percent Owner |
RSU 付与（制限付株式） |
5,250 |
- |
- |
5,250 |
| 2025-06-04 |
Seth Alpna |
Director |
RSU 付与（制限付株式） |
5,250 |
- |
- |
5,250 |
| 2025-06-04 |
Farzan Nima |
Director |
RSU 付与（制限付株式） |
5,250 |
- |
- |
5,250 |
| 2025-06-04 |
Knowles Julius |
Director |
RSU 付与（制限付株式） |
5,250 |
- |
- |
6,441 |
| 2025-06-04 |
Kariv Tomer |
Officer |
不明 |
- |
- |
- |
- |
| 2025-06-04 |
Nussbaum Ran |
Officer |
不明 |
- |
- |
- |
- |
| 2025-05-16 |
Adar1 Capital Management, Llc |
10 Percent Owner |
オプション失効 |
178 |
$10.00 |
$1.78K |
- |
| 2025-04-09 |
Adar1 Capital Management, Llc |
10 Percent Owner |
その他（売り） |
74,333 |
- |
- |
50,000 |
| 2025-04-08 |
Adar1 Capital Management, Llc |
10 Percent Owner |
不明 |
949,333 |
- |
- |
- |
| 2025-04-04 |
Seehra Jasbir |
Chief Executive Officer |
オプション行使（売却） |
49,367 |
$0.30 |
$14.81K |
252,444 |
| 2025-04-03 |
Adar1 Capital Management, Llc |
10 Percent Owner |
不明 |
17,800 |
$10.00 |
$178K |
- |
| 2025-02-18 |
Regnante Keith |
Chief Financial Officer |
RSU 付与（制限付株式） |
44,000 |
- |
- |
44,000 |
| 2025-02-18 |
Rovaldi Christopher |
Chief Operating Officer |
RSU 付与（制限付株式） |
60,000 |
- |
- |
60,000 |
| 2025-02-18 |
Chyung Yung H. |
Chief Medical Officer |
RSU 付与（制限付株式） |
44,000 |
- |
- |
44,000 |
| 2024-11-08 |
Chyung Yung H. |
Chief Medical Officer |
RSU 付与（制限付株式） |
110,000 |
$67.91 |
$7.47M |
110,000 |
| 2024-11-01 |
Chyung Yung H. |
Officer |
不明 |
- |
- |
- |
- |
| 2024-10-02 |
Adar1 Capital Management, Llc |
10 Percent Owner |
不明 |
100 |
$60.00 |
$6K |
- |
| 2024-10-01 |
Adar1 Capital Management, Llc |
10 Percent Owner |
不明 |
200 |
$70.00 |
$14K |
- |
| 2024-08-13 |
Orbimed Advisors Llc |
Director |
情報に基づく売り |
29,400 |
$44.01 |
$1.29M |
119,522 |
| 2024-08-13 |
Gordon Carl L |
Director |
情報に基づく売り |
29,400 |
$44.01 |
$1.29M |
119,522 |
| 2024-06-03 |
Bienaime Jean Jacques |
Director |
RSU 付与（制限付株式） |
17,600 |
$48.67 |
$856.59K |
17,600 |
| 2024-06-01 |
Bienaime Jean Jacques |
Director |
処分 |
- |
- |
- |
200 |
| 2024-05-30 |
Gray Mary Ann |
Director |
RSU 付与（制限付株式） |
10,000 |
$46.31 |
$463.1K |
10,000 |
| 2024-05-30 |
Gordon Carl L |
Director |
RSU 付与（制限付株式） |
10,000 |
$46.31 |
$463.1K |
10,000 |
| 2024-05-30 |
Kariv Tomer |
10 Percent Owner |
RSU 付与（制限付株式） |
10,000 |
$46.31 |
$463.1K |
10,000 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
